Delivery Order SPE2DB20D3303-SPE2DB24FA2RE

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 50 MG TABLET 100S. The contract has a ceiling value of $1,837.56 and a period of performance through June 23, 2025. It is a firm fixed-price contract awarded without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,225.04 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of NUCYNTA 100 MG TABLET 100S. The contract is a Firm Fixed Price agreement with a ceiling value of $1,908.18 and a completion date of June 10, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $1,330.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,184.05, is for the delivery of NUCYNTA tablets, a pain medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 31, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,311.84, is for the supply of 100 units of the medication NUCYNTA 50 MG TABLET. The award has an ultimate completion date of June 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUCYNTA 50 MG TABLET 100S, a pain management pharmaceutical product. The contract has a firm fixed price of $1,158.95 and a completion date of June 13, 2025. The contract is not set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,027.35 firm fixed-price contract is for the supply of NUCYNTA, a prescription pain medication, to support federal healthcare programs. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,225.04, is for the delivery of 4,568,059,518 units of the pharmaceutical product NUCYNTA 50 MG TABLET 100S. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. This contract is not designated as a set-aside and was open to full and open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $2,290.34 and a period of performance ending on June 4, 2025. The contract is a firm fixed-price delivery order and is not set aside for any special designation. AmerisourceBergen Drug Corp holds a...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2RE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 50 MG tablet prescription medication. The contract has a firm-fixed price of $1,155.92 and an ultimate completion date of September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which serves as a primary vehicle for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/3/24, 10:07 AM